Conditions: Ocular Hypertension Glaucoma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 586
Healthy volunteers: no

Brief summary:
The study will compare the safety and efficacy of Bimatoprost and Latanoprost in patients with glaucoma or ocular hypertension

Detailed description:

Arms:
arm 1: bimatoprost 0.03% eye drops arm 2: latanoprost 0.005% eye drops

Interventions: intervention 1: bimatoprost 0.03% eye drops intervention 2: latanoprost 0.005% eye drops
Intervention descriptions: intervention 1: Open-labeled latanoprost 0.005% 1 drop into each eye every evening for 6 weeks followed by a masked randomized treatment of bimatoprost 0.03% 1 drop every evening for 12 weeks intervention 2: Open-labeled latanoprost 0.005% 1 drop into each eye every evening for 6 weeks followed by a masked randomized treatment of latanoprost 0.005% 1 drop every evening for 12 weeks

Protocol document: